Log in

Group activity

    • Veilleux
      The drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH). The firearm in question, a Diamondback...